DexCom, Inc. (ETR:DC4)

Germany · Delayed Price · Currency is EUR

57.03

+1.88 (3.41%)

At close: Dec 5, 2025

-26.06% (1Y)

Market Cap	21.96B
Revenue (ttm)	3.85B
Net Income (ttm)	614.25M
Shares Out	n/a
EPS (ttm)	1.53
PE Ratio	35.74
Forward PE	26.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Average Volume	279
Open	56.34
Previous Close	55.15
Day's Range	56.34 - 57.03
52-Week Range	47.00 - 88.54
Beta	n/a
RSI	60.18
Earnings Date	Feb 13, 2026

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus

Founded 1999

Employees 10,300

Stock Exchange Deutsche Börse Xetra

Ticker Symbol DC4

Full Company Profile

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD Financial Statements

News

There is no news available yet.